Page last updated: 2024-11-04

4-carboxyphenylglycine and Brain Ischemia

4-carboxyphenylglycine has been researched along with Brain Ischemia in 2 studies

4-carboxyphenylglycine: RN given for (+-)-isomer; RN for cpd without isomeric designation not available 3/93; glutamate receptor antagonist

Brain Ischemia: Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Soria, FN1
Pérez-Samartín, A1
Martin, A1
Gona, KB1
Llop, J1
Szczupak, B1
Chara, JC1
Matute, C1
Domercq, M1
Henrich-Noack, P1
Reymann, KG1

Other Studies

2 other studies available for 4-carboxyphenylglycine and Brain Ischemia

ArticleYear
Extrasynaptic glutamate release through cystine/glutamate antiporter contributes to ischemic damage.
    The Journal of clinical investigation, 2014, Volume: 124, Issue:8

    Topics: Amino Acid Transport System y+; Animals; Benzoates; Brain Ischemia; Cell Death; Glutamate Plasma Mem

2014
(1S,3R)-ACPD, a metabotropic glutamate receptor agonist, enhances damage after global ischaemia.
    European journal of pharmacology, 1999, Jan-15, Volume: 365, Issue:1

    Topics: Animals; Benzoates; Brain Ischemia; Cell Count; Cell Survival; Cycloleucine; Dose-Response Relations

1999